NBER Working Papers by Ernst R. Berndt

Contact and additional information for this authorAll papers and publicationsWorking Papers onlyWorking Papers with publication info

Working Papers

March 2014Specialty Drug Prices and Utilization After Loss of U.S. Patent Exclusivity, 2001-2007
with Rena M. Conti: w20016
October 2013The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity
with Murray L. Aitken, Barry Bosworth, Iain M. Cockburn, Richard Frank, Michael Kleinrock, Bradley T. Shapiro: w19487
March 2013Price Indexes for Clinical Trial Research: A Feasibility Study
with Iain M. Cockburn: w18918
October 2011The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts
with Rena M. Conti, Haiden A. Huskamp: w17528
March 2011A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets
with Thomas G. McGuire, Joseph P. Newhouse: w16879
February 2011The Diversity of Concentrated Prescribing Behavior: An Application to Antipsychotics
with Anna A. Levine Taub, Anton Kolotilin, Robert S. Gibbons: w16823
October 2010Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation
with Murray L. Aitken: w16431
August 2010Pricing and Reimbursement in U.S. Pharmaceutical Markets
with Joseph P. Newhouse: w16297
May 2010Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?
with Mark Trusheim, Murray L. Aitken: w16014
September 2008Economic Factors Underlying the Unbundling of Advertising Agency Services
with Mohammad Arzaghi, James C. Davis, Alvin J. Silk: w14345
December 2006Anomalies in Estimates of Cross-Price Elasticities for Marketing Mix Models: Theory and Empirical Test
with Andre Bonfrer, Alvin Silk: w12756
May 2006Early Retirement and Public Disability Insurance Applications: Exploring the Impact of Depression
with Rena M. Conti, Richard G. Frank: w12237
March 2006The Impact of Antihypertensive Drugs on the Number and Risk of Death, Stroke and Myocardial Infarction in the United States
with Genia Long, David Cutler, Jimmy Royer, Andrée-Anne Fournier, Alicia Sasser, Pierre Cremieux: w12096
October 2005Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
with Tomas J. Philipson, Adrian H. B. Gottschalk, Matthew W. Strobeck: w11724
August 2005Real Output in Mental Health Care During the 1990s
with Alisa B. Busch, Richard G. Frank, Sharon-Lise Normand: w11557
June 2005Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA
with Adrian H. B. Gottschalk, Matthew W. Strobeck: w11425
May 2005Advanced Purchase Commitments for a Malaria Vaccine: Estimating Costs and Effectiveness
with Rachel Glennerster, Michael R. Kremer, Jean Lee, Ruth Levine, Georg Weizsacker, Heidi Williams: w11288
October 2004Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
with Adrian H. B. Gottschalk, Tomas Philipson, Matthew W. Strobeck: w10822
September 2004Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs
with Paul D. Chwelos, Ernst R. Berndt, Iain M. Cockburn: w10746
April 2004Hedonic Price Indexes for Personal Computer Operating Systems and Productivity Suites
with Alan G. White, Jaison R. Abel, Cory W. Monroe: w10427
November 2003Benefit Plan Design and Prescription Drug Utilization Among Asthmatics: Do Patient Copayments Matter?
with William H. Crown, Onur Baser, Stan N. Finkelstein, Whitney P. Witt: w10062
October 2003Quality-Constant Price Indexes for the Ongoing Treatment of Schizophrenia: An Exploratory Study
with Richard G. Frank, Alisa B. Busch: w10022
September 2003Price Indexes for Microsoft's Personal Computer Software Products
with Jaison R. Abel, Alan G. White: w9966
Scale and Scope Economies in the Global Advertising and Marketing Services Business
with Alvin J. Silk: w9965
December 2001Intermedia Substitutability and Market Demand by National Advertisers
with Alvin J. Silk, Lisa R. Klein: w8624
July 2000The Medical Treatment of Depression, 1991-1996: Productive Inefficiency, Expected Outcome Variations, and Price Indexes
with Anupa Bir, Susan H. Busch, Richard G. Frank, Sharon-Lise T. Normand: w7816
June 2000Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
with Robert S. Pindyck, Pierre Azoulay: w7772
March 1999Network Effects and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
with Robert S. Pindyck, Pierre Azoulay: w7024
November 1998Price Indexes for Acute Phase Treatment of Depression
with Susan H. Busch, Richard G. Frank: w6799
Price Indexes for Medical Care Goods and Services: An Overview of Measurement Issues
with David M. Cutler, Richard G. Frank, Zvi Griliches, Joseph P. Newhouse: w6817
February 1998Price Indexes for the Treatment of Depression
with Richard G. Frank, Susan H. Busch: w6417
September 1997Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs
with Iain M. Cockburn, Douglas L. Cocks, Arnold Epstein, Zvi Griliches: w6182
November 1996Alternate Insurance Arrangements and the Treatment of Depression: What Are the Facts?
with Richard G. Frank, Thomas G. McGuire: w5813
October 1994The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry
with Linda Bui, David Reiley, Glen Urban: w4904
August 1994Costs, Institutional Mobility Barriers, and Market Structure: Advertising Agencies as Multiproduct Firms
with Alvin J. Silk: w4826
November 1993Econometric Estimates of Prices Indexes for Personal Computers in the 1990s
with Zvi Griliches, Neal Rappaport: w4549
March 1992Auditing the Producer Price Index: Micro Evidence From Prescription Pharmaceutical Preparations
with Zvi Griliches, Joshua G. Rosett: w4009
High-Tech Capital Formation and Labor Composition in U.S. Manufacturing Industries: An Exploratory Analysis
with Catherine J. Morrison, Larry S. Rosenblum: w4010
September 1991Rail Costs and Capital Adjustments in a Quasi-Regulated Environment
with Ann F. Friedlaender, Judy Shaw-Er Wang Chiang, Mark Showalter, Christopher A. Vellturo: w3841
Measuring the Contribution of Public Infrastructure Capital in Sweden
with Bengt Hansson: w3842
June 1991Mergers, Deregulation and Cost Savings in the U.S. Rail Industry
with Ann F. Friedlaender, Judy Shaw-Er Wang Chiang, Christopher A. Vellturo: w3749
January 1991Assessing the Productivity of Information Technology Equipment in U.S. Manufacturing Industries
with Catherine J. Morrison: w3582
October 1990Scale and Scope Effects on Advertising Agency Costs
with Alvin J. Silk: w3463
On the Accuracy of Producer Price Indexes for Pharmaceutical Preparations: An Audit Based on Detailed Firm-Specific Data
with Zvi Griliches, Joshua G. Rosett: w3490
June 1990Price Indexes for Microcomputers: An Exploratory Study
with Zvi Griliches: w3378
Interdependent Pricing and Markup Behavior: An Empirical Analysis of GM, Ford and Chrysler
with Ann F. Friedlaender, Judy Shaw-Er Wang Chiang: w3396
April 1989Economic Capacity Utilization and Productivity Measurement for Multi-product firms with multiple quasi-fixed inputs
with Melvyn A. Fuss: w2932
May 1982Productivity Measurement Using Capital Asset Valuation to Adjust for Variations in Utilization
with Melvyn A. Fuss: w0895

Contact and additional information for this authorAll papers and publicationsWorking Papers onlyWorking Papers with publication info


National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us